First Washington Corp Pfizer Inc Transaction History

First Washington Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $2.39 Million - $3.12 Million	-57,217 Reduced 91.96%	5,000 $256,000
Q1 2022 May 11, 2022	BUY	$45.75 - $56.69 $2.62 Million - $3.24 Million	57,217 Added 1144.34%	62,217 $3.22 Million
Q2 2021 Aug 12, 2021	SELL	$35.91 - $40.68 $4.24 Million - $4.8 Million	-118,000 Reduced 95.93%	5,000 $196,000
Q1 2021 May 13, 2021	BUY	$33.49 - $37.77 $3.95 Million - $4.46 Million	118,000 Added 2360.0%	123,000 $4.46 Million
Q2 2020 Aug 13, 2020	SELL	$30.12 - $36.54 $828,300 - $1 Million	-27,500 Reduced 84.62%	5,000 $164,000
Q1 2020 May 08, 2020	BUY	$27.03 - $38.62 $743,325 - $1.06 Million	27,500 Added 550.0%	32,500 $1.06 Million
Q4 2019 Feb 10, 2020	SELL	$32.92 - $37.36 $13,168 - $14,944	-400 Reduced 7.41%	5,000 $196,000
Q3 2018 Nov 13, 2018	BUY	$34.47 - $41.81 $13,788 - $16,724	400 Added 8.0%	5,400 $238,000
Q3 2017 Nov 07, 2017	BUY	$31.0 - $34.15 $155,000 - $170,750	5,000	5,000 $179,000

3,218

3.71B

73.2M

108M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $167B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of First Washington Corp, based on Form 13F filings with the SEC.

Stay updated on First Washington Corp with notifications on news.